Background: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is implicated in
atherosclerotic plaque vulnerability. It is shed, in part, by proteases and released as soluble …

Aims The lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and its shedding
product [soluble LOX-1 (sLOX-1)] are implicated in atherosclerotic cardiovascular disease …

Background: Cardiac troponin is the best marker to diagnose acute coronary syndrome
(ACS). However, early diagnosis using markers for plaque instability may be of significance …

BACKGROUND: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) appears to
be involved in atherosclerotic plaque vulnerability and rupture. Circulating soluble LOX-1 …

Background—Markers of cardiac injury, including troponin-T (TnT), are used to diagnose
acute coronary syndrome (ACS); however, markers for plaque instability may be more useful …

Background: Soluble lectin-like oxidized low-density lipoprotein receptor-1 (sLOX-1) level is
a reliable prognostic biomarker in acute coronary syndrome. However, it is unclear whether …

Sažetak Introduction: Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is
involved in the pathophysiology of atherosclerosis and acute coronary syndromes (ACS) …

BACKGROUND:: Although serum soluble lectin-like oxidized low-density lipoprotein
receptor-1 (sLOX-1) is reported to be associated with acute coronary syndrome (ACS), its …

Background: The diagnostic sensitivity of myocardial necrosis markers, such as creatine
kinase-MB (CK-MB), cardiac troponins, myoglobin and heart-type fatty acid-binding protein …

Lectin‐like oxidized low density lipoprotein receptor‐1 (LOX‐1), the main oxidized low‐
density lipoprotein (OxLDL) in endothelial cells, is upregulated in atherosclerotic lesions and …